期刊文献+

人血小板/T细胞活化抗原PTA1/Ig融合蛋白表达载体的构建、表达及鉴定 被引量:4

Construction and expression of a novel human platelet/T cell activation antigen 1 (PTA1) fusion protein in COS 7 cells
原文传递
导出
摘要 目的:获得人血小板/T细胞活化抗原1(plateletandTcelactivationantigen1,PTA1)胞膜外区与人IgG1Fc段融合蛋白,为PTA1配体的鉴定及其功能的研究提供有力的工具。方法:针对人PTA1cDNA序列设计3段引物,通过反转录、半套式PCR方法从活化Jurkat细胞中扩增出PTA1胞膜外区基因片段,并将其克隆入融合蛋白表达载体pIG中,通过酶切、PCR及序列测定鉴定重组表达载体。重组载体通过DEAEdextran法转染COS7细胞,经夹心ELISA及亲和层析、SDSPAGE鉴定融合蛋白的表达及免疫学活性。结果:经序列测定后证实重组表达载体含有正确的PTA1胞膜外区序列及剪接供体序列,转染COS7细胞后,通过亲和层析纯化证实融合蛋白的Mr为83000,并能被抗PTA1胞膜外区单抗及抗人IgGFc的单抗同时识别。结论:pPTA1/Ig融合表达载体的构建及表达成功,为PTA1的功能及配体(PTA1L)的研究打下了良好的基础。 Aim: Platelet and T cell activation antigen 1 (PTA1) is a novel member of immunoglobulin superfamily. Its ligand and function is still not clear. The aim of this paper is to express and purify the PTA1 IgGFc fusion protein for further research on PTA1 ligand and its function. Methods: we amplified the 800bp extracellular region of PTA1 cDNA by RT PCR from activated Jurkat cell, and cloned this fragment into fusion expression vector pIG. The recombinant vector pPTA1/Ig was obtained after sequencing and PCR identification. After transfection of pPTA1/Ig into COS 7 cells by DEAE dextran, expression of a secreting fusion protein was identified by affinity chromatography and sandwich ELISA assay with anti PTA1 mAb and HRP anti hIgFc mAb. Results: The correct insertion of PTA1 extracellular region and splicer donor sequence into pIG vector was identified. After transfection of pPTA1/Ig into COS 7 cells, a M r83 000 secreting protein was obtained by anti PTA1 mAb affinity chromatography, and this protein could also be recognized by both anti PTA1 and anti hIgFc mAb. Conclusion: This fusion protein could mimic the nature PTA1 protein and could be used as a potential tool in the investigation of PTA1 ligand and function.
出处 《细胞与分子免疫学杂志》 CAS CSCD 1998年第1期1-4,共4页 Chinese Journal of Cellular and Molecular Immunology
基金 国家自然科学基金
关键词 人血小板 T细胞活化抗原 PTA1 融合蛋白 表达 PTA1 fusion protein expression
  • 相关文献

参考文献4

二级参考文献4

共引文献9

同被引文献22

  • 1刘雪松,金伯泉,许辉,朱勇,孙忱,李琦.抗重组人肿瘤坏死因子-α单克隆抗体的研制及其初步应用[J].单克隆抗体通讯,1995,11(2):8-11. 被引量:9
  • 2金冬雁 黎孟枫 等.分子克隆(第二版)[M].北京:科技出版社,1992.363.
  • 3金伯泉,细胞和分子免疫学,1995年
  • 4Huang C,J Infect Dis,1994年,169卷,868页
  • 5刘智广,单克隆抗体通讯,1994年,10卷,3期,43页
  • 6Soctt J L,J Biol Chem,1989年,264卷,13475页
  • 7SchultzeJ,NadlerLM,GribbenJG.B7-mediatedcostimulationandtheimmuneresponse.BloodRev,1996;10:111-127
  • 8McLellanAD,SorgRV,WilliamsLA,etal.HumandendriticcellsactivateTlymphocytesviaaCD40:CD40ligand-dependentpathway.Eur.JImmunol,1996;26:1204-1210
  • 9GrewalIS,FlavellRA.AcentralroleofCD40ligandintheregulationofCD4+T-cellresponses.ImmunolToday,1996;17:410-414
  • 10BanchereauJ,BazanF,BlanchardD,etal.TheCD40antigenanditsligand.AnnuRevImmunol,1994;12:881-922

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部